News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here.

Recommended Reading

Morgan Leary Vaughan Foundation
MDedge Hematology and Oncology
Osteogenesis Imperfecta Foundation (OIF)
MDedge Hematology and Oncology
Patidegib, the first topical hedgehog inhibitor, scores in Gorlin syndrome
MDedge Hematology and Oncology
Malignant pleural mesothelioma guidelines often are ignored
MDedge Hematology and Oncology
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
MDedge Hematology and Oncology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Hematology and Oncology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Hematology and Oncology
RFPs Available for the Study of Three Rare Diseases
MDedge Hematology and Oncology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Hematology and Oncology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Hematology and Oncology